Trials / Conditions / Stage III Uveal Melanoma AJCC v7
Stage III Uveal Melanoma AJCC v7
3 registered clinical trials studyying Stage III Uveal Melanoma AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors Th NCT03326258 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma NCT02068586 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma NCT01835145 | National Cancer Institute (NCI) | Phase 2 |